norfloxacin has been researched along with 1,10-phenanthroline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bohnert, JA; Karamian, B; Nikaido, H | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Baptista, T; de Castro, B; Gameiro, P; Rodrigues, C; Sousa, I | 1 |
Efthimiadou, EK; Karaliota, A; Katsarou, ME; Psomas, G; Vourloumis, D | 1 |
4 other study(ies) available for norfloxacin and 1,10-phenanthroline
Article | Year |
---|---|
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Solution studies on binary and ternary complexes of copper(II) with some fluoroquinolones and 1,10-phenanthroline: Antimicrobial activity of ternary metalloantibiotics.
Topics: Anti-Bacterial Agents; Copper; Drug Design; Drug Resistance, Microbial; Drug Stability; Ligands; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Phenanthrolines; Potentiometry; Spectrophotometry, Ultraviolet | 2007 |
Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Copper; Deoxyribonucleases; DNA, Superhelical; Escherichia coli; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Necrosis; Norfloxacin; Organometallic Compounds; Phenanthrolines; Pseudomonas aeruginosa; Staphylococcus aureus | 2008 |